Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.

Article  PubMed  Google Scholar 

Dani SS, Lone AN, Javed Z, Khan MS, Zia Khan M, Kaluski E, et al. Trends in premature mortality from acute myocardial infarction in the United States, 1999 to 2019. J Am Heart Assoc. 2022;11:e021682.

Article  PubMed  Google Scholar 

Khera R, Haimovich J, Hurley NC, McNamara R, Spertus JA, Desai N, et al. Use of machine learning models to predict death after acute myocardial infarction. JAMA Cardiol. 2021;6:633–41.

Article  PubMed  Google Scholar 

Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50:2173–95.

Article  PubMed  Google Scholar 

Blue L, Kranker K, Markovitz AR, Powell RE, Williams MV, Pu J, et al. Effects of the million hearts model on myocardial infarctions, strokes, and medicare spending: a randomized clinical trial. JAMA. 2023;330:1437–47.

Article  PubMed  PubMed Central  Google Scholar 

Stevens W, Peneva D, Li JZ, Liu LZ, Liu G, Gao R, et al. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China. BMC Health Serv Res. 2016;16:175.

Article  PubMed  PubMed Central  Google Scholar 

Windecker S, Bax JJ, Myat A, Stone GW, Marber MS. Future treatment strategies in ST-segment elevation myocardial infarction. Lancet. 2013;382:644–57.

Article  PubMed  Google Scholar 

James SK, Spertus JA. Evidence-based treatments for STEMI: are we doing enough? Lancet. 2013;382:576–9.

Article  PubMed  Google Scholar 

Zhang Z, Zhao X, Gao M, Xu L, Qi Y, Wang J, et al. Dioscin alleviates myocardial infarction injury via regulating BMP4/NOX1-mediated oxidative stress and inflammation. Phytomedicine. 2022;103:154222.

Article  PubMed  CAS  Google Scholar 

Li H, Zhu J, Xu YW, Mou FF, Shan XL, Wang QL, et al. Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction. Redox Biol. 2022;54:102384.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang ZC, Niu KM, Wu YJ, Du KR, Qi LW, Zhou YB, et al. A dual Keap1 and p47(phox) inhibitor Ginsenoside Rb1 ameliorates high glucose/ox-LDL-induced endothelial cell injury and atherosclerosis. Cell Death Dis. 2022;13:824.

Article  PubMed  PubMed Central  Google Scholar 

James J, Dubery I. Identification and quantification of triterpenoid centelloids in Centella asiatica (L.) Urban by densitometric TLC. J Planar Chromatogr-Mod TLC. 2011;24:82–7.

Article  CAS  Google Scholar 

Hashim P, Sidek H, Helan MH, Sabery A, Palanisamy UD, Ilham M. Triterpene composition and bioactivities of Centella asiatica. Molecules. 2011;16:1310–22.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Choi SW, Cho W, Oh H, Abd El-Aty AM, Hong SA, Hong M, et al. Madecassoside ameliorates hepatic steatosis in high-fat diet-fed mice through AMPK/autophagy-mediated suppression of ER stress. Biochem Pharmacol. 2023;217:115815.

Article  PubMed  CAS  Google Scholar 

Bandopadhyay S, Mandal S, Ghorai M, Jha NK, Kumar M, Radha, et al. Therapeutic properties and pharmacological activities of asiaticoside and madecassoside: a review. J Cell Mol Med. 2023;27:593–608.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bian GX, Li GG, Yang Y, Liu RT, Ren JP, Wen LQ, et al. Madecassoside reduces ischemia-reperfusion injury on regional ischemia induced heart infarction in rat. Biol Pharm Bull. 2008;31:458–63.

Article  PubMed  CAS  Google Scholar 

Bian D, Liu M, Li Y, Xia Y, Gong Z, Dai Y. Madecassoside, a triterpenoid saponin isolated from Centella asiatica herbs, protects endothelial cells against oxidative stress. J Biochem Mol Toxicol. 2012;26:399–406.

Article  PubMed  CAS  Google Scholar 

Zhang P, Zhang D, Zhou W, Wang L, Wang B, Zhang T, et al. Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine. Brief Bioinform. 2023;25:bbad518. https://doi.org/10.1093/bib/bbad518.

Li X, Liu Z, Liao J, Chen Q, Lu X, Fan X. Network pharmacology approaches for research of Traditional Chinese Medicines. Chin J Nat Med. 2023;21:323–32.

PubMed  Google Scholar 

Zhao L, Zhang H, Li N, Chen J, Xu H, Wang Y, et al. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol. 2023;309:116306.

Article  PubMed  CAS  Google Scholar 

Zhou J, Chen F, Yan A, Xia X. Madecassoside protects retinal pigment epithelial cells against hydrogen peroxide-induced oxidative stress and apoptosis through the activation of Nrf2/HO-1 pathway. Biosci Rep. 2020;40:BSR20194347.

Shan RR, Yu JT, Zhang SF, Xie MM, Hou R, Xie CY, et al. Madecassoside alleviates acute kidney injury by regulating JNK-mediated oxidative stress and programmed cell death. Phytomedicine. 2024;123:155252.

Article  PubMed  CAS  Google Scholar 

Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundbäck T, Nordlund P, et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc. 2014;9:2100–22.

Article  PubMed  CAS  Google Scholar 

Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.

Article  PubMed  PubMed Central  Google Scholar 

Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47:W357–W64.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X, et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45:W356–W60.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Luo H, Chen J, Shi L, Mikailov M, Zhu H, Wang K, et al. DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome. Nucleic Acids Res. 2011;39:W492–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Guo Q, Li Q, Liang W, Zhang Y, Jiang C, Zhang Y, et al. Asiatic acid and madecassic acid cause cardiotoxicity via inflammation and production of excessive reactive oxygen species in zebrafish. J Appl Toxicol. 2024;44:1028–39.

Article  PubMed  CAS  Google Scholar 

Junsai T, Tangpanithandee S, Srimangkornkaew P, Suknuntha K, Vivithanaporn P, Khemawoot P. Sub-chronic oral toxicity of a water-soluble extract of Centella asiatica (Centell-S) in Wistar rats. Food Chem Toxicol. 2024;185:114509.

Article  PubMed  CAS  Google Scholar 

Das SK, Yuan YF, Li MQ. Specific PKC βII inhibitor: one stone two birds in the treatment of diabetic foot ulcers. Biosci Rep. 2018;38:BSR20171459.

Wang F, Huang D, Zhu W, Li S, Yan M, Wei M, et al. Selective inhibition of PKCβ2 preserves cardiac function after myocardial infarction and is associated with improved angiogenesis of ischemic myocardium in diabetic rats. Int J Mol Med. 2013;32:1037–46.

Article  PubMed  Google Scholar 

Burkey JL, Campanale KM, Barbuch R, O’Bannon D, Rash J, Benson C, et al. Disposition of [14C]ruboxistaurin in humans. Drug Metab Dispos. 2006;34:1909–17.

Article  PubMed  CAS  Google Scholar 

Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, et al. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clin Ther. 2005;27:1164–80.

Article  PubMed  CAS  Google Scholar